BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Cash Flow
Canada - TSX:BCT - CA1079303071 - Common Stock
10.78 CAD
-2.15 (-16.63%)
| 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.56M | -4.93M | -20.30M | -26.84M | -13.82M | |||
| Depreciation Amortization | 106.60K | 83.90K | 15.30K | 15.30K | 15.30K | |||
| Income Taxes - Deferred | null | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -1.91M | 7.05M | -3.53M | -391.30K | -2.28M | |||
| Interest Paid | null | null | null | null | null | |||
| Taxes Paid | null | null | null | null | null | |||
| Other non cash items | 186.30K | -26.33M | 74.30K | 14.73M | 8.33M | |||
| OPERATING CASH FLOW | -28.17M | -24.13M | -23.74M | -12.48M | -7.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0 | -456.80K | null | null | null | |||
| Other Investing Activity | -7.65M | -225.00K | null | null | 0 | |||
| INVESTING CASH FLOW | -7.65M | -681.80K | null | null | 0 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | null | null | 0 | -23.60K | -330.40K | |||
| Stock Issued/Repurchased | 45.45M | 4.42M | 3.95M | -3.66M | 65.33M | |||
| Dividend Paid | null | null | null | null | null | |||
| Other Financing Activity | null | null | 0 | -57.10K | 0 | |||
| FINANCING CASH FLOW | 45.45M | 4.42M | 3.95M | -3.74M | 65.00M | |||
| Exchange Rate Effect | null | null | null | null | 0 | |||
| CHANGE IN CASH | 9.63M | -20.39M | -19.79M | -16.23M | 57.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.17M | -24.13M | -23.74M | -12.48M | -7.75M | |||
| Capital Expenditure | 0 | -456.80K | null | null | null | |||
| FREE CASH FLOW | -28.17M | -24.58M | -23.74M | -12.48M | -7.75M | |||
All data in USD